 Connection
Todd Bull to Anticoagulants
This is a "connection" page, showing publications Todd Bull has written about Anticoagulants.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.397 |
|
|
|
-
Bull TM. Clotting and COVID-19. Chest. 2021 06; 159(6):2151-2152.
Score: 0.133
-
White D, MacDonald S, Bull T, Hayman M, de Monteverde-Robb R, Sapsford D, Lavinio A, Varley J, Johnston A, Besser M, Thomas W. Heparin resistance in COVID-19 patients in the intensive care unit. J Thromb Thrombolysis. 2020 Aug; 50(2):287-291.
Score: 0.125
-
Hunt JM, Bull TM. Clinical review of pulmonary embolism: diagnosis, prognosis, and treatment. Med Clin North Am. 2011 Nov; 95(6):1203-22.
Score: 0.068
-
Piazza G, Spyropoulos AC, Hsia J, Goldin M, Towner WJ, Go AS, Bull TM, Weng S, Lipardi C, Barnathan ES, Bonaca MP. Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial. Circulation. 2023 06 20; 147(25):1891-1901.
Score: 0.038
-
Bradley M, Bull T, Hountras P, MacLaren R. Pragmatic Use of Catheter-Directed Thrombolysis in Venous Thromboembolism and a Comparative Evaluation With Traditional Therapies in Submassive Pulmonary Embolism. J Pharm Pract. 2022 Oct; 35(5):738-746.
Score: 0.033
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|